135 related articles for article (PubMed ID: 32056524)
1. Liposomal Formulation of a Melphalan Lipophilic Prodrug: Studies of Acute Toxicity, Tolerability, and Antitumor Efficacy.
Tretiakova D; Svirshchevskaya E; Onishchenko N; Alekseeva A; Boldyrev I; Kamyshinsky R; Natykan A; Lokhmotov A; Arantseva D; Shobolov D; Vodovozova E
Curr Drug Deliv; 2020; 17(4):312-323. PubMed ID: 32056524
[TBL] [Abstract][Full Text] [Related]
2. Phosphatidylinositol Stabilizes Fluid-Phase Liposomes Loaded with a Melphalan Lipophilic Prodrug.
Tretiakova D; Le-Deigen I; Onishchenko N; Kuntsche J; Kudryashova E; Vodovozova E
Pharmaceutics; 2021 Apr; 13(4):. PubMed ID: 33915726
[TBL] [Abstract][Full Text] [Related]
3. Influence of stabilizing components on the integrity of antitumor liposomes loaded with lipophilic prodrug in the bilayer.
Tretiakova D; Onishchenko N; Boldyrev I; Mikhalyov I; Tuzikov A; Bovin N; Evtushenko E; Vodovozova E
Colloids Surf B Biointerfaces; 2018 Jun; 166():45-53. PubMed ID: 29533843
[TBL] [Abstract][Full Text] [Related]
4. Formulation optimization of an ephrin A2 targeted immunoliposome encapsulating reversibly modified taxane prodrugs.
Huang ZR; Tipparaju SK; Kirpotin DB; Pien C; Kornaga T; Noble CO; Koshkaryev A; Tran J; Kamoun WS; Drummond DC
J Control Release; 2019 Sep; 310():47-57. PubMed ID: 31400383
[TBL] [Abstract][Full Text] [Related]
5. [Liposome formulations of combretastatin A4 and 4-arylcoumarin analog prodrugs: antitumor effect in the mouse model of breast cancer].
Mouseeva EV; Kuznetsova NR; Svirshchevskaia EV; Bovin NV; Sitnikov NC; Shavyrin AS; Beletskaia IP; Combes S; Fedorov AIu; Vodovozova EL
Biomed Khim; 2012; 58(3):326-38. PubMed ID: 22856138
[TBL] [Abstract][Full Text] [Related]
6. Liposomal formulation of a methotrexate lipophilic prodrug: assessment in tumor cells and mouse T-cell leukemic lymphoma.
Alekseeva AA; Moiseeva EV; Onishchenko NR; Boldyrev IA; Singin AS; Budko AP; Shprakh ZS; Molotkovsky JG; Vodovozova EL
Int J Nanomedicine; 2017; 12():3735-3749. PubMed ID: 28553111
[TBL] [Abstract][Full Text] [Related]
7. Development of a Liposomal Formulation of Acetyltanshinone IIA for Breast Cancer Therapy.
Wang Q; Luo M; Wei N; Chang A; Luo KQ
Mol Pharm; 2019 Sep; 16(9):3873-3886. PubMed ID: 31389706
[TBL] [Abstract][Full Text] [Related]
8. Reduced toxicity and superior therapeutic activity of a mitomycin C lipid-based prodrug incorporated in pegylated liposomes.
Gabizon AA; Tzemach D; Horowitz AT; Shmeeda H; Yeh J; Zalipsky S
Clin Cancer Res; 2006 Mar; 12(6):1913-20. PubMed ID: 16551877
[TBL] [Abstract][Full Text] [Related]
9. Interactions of antitumour Sialyl Lewis X liposomes with vascular endothelial cells.
Alekseeva A; Kapkaeva M; Shcheglovitova O; Boldyrev I; Pazynina G; Bovin N; Vodovozova E
Biochim Biophys Acta; 2015 May; 1848(5):1099-110. PubMed ID: 25646577
[TBL] [Abstract][Full Text] [Related]
10. A novel melphalan polymeric prodrug: preparation and property study.
Li D; Lu B; Huang Z; Xu P; Zheng H; Yin Y; Xu H; Liu X; Chen L; Lou Y; Zhang X; Xiong F
Carbohydr Polym; 2014 Oct; 111():928-35. PubMed ID: 25037433
[TBL] [Abstract][Full Text] [Related]
11. Immunotargeting of liposomes containing lipophilic antitumor prodrugs.
Mori A; Kennel SJ; Huang L
Pharm Res; 1993 Apr; 10(4):507-14. PubMed ID: 8483832
[TBL] [Abstract][Full Text] [Related]
12. Secretory phospholipase A2 as a tumor-specific trigger for targeted delivery of a novel class of liposomal prodrug anticancer etherlipids.
Jensen SS; Andresen TL; Davidsen J; Høyrup P; Shnyder SD; Bibby MC; Gill JH; Jørgensen K
Mol Cancer Ther; 2004 Nov; 3(11):1451-8. PubMed ID: 15542784
[TBL] [Abstract][Full Text] [Related]
13. Design and preparation of pH-sensitive cytotoxic liposomal formulations containing antitumor colchicine analogues for target release.
Shchegravina ES; Tretiakova DS; Sitdikova AR; Usova SD; Boldyrev IA; Alekseeva AS; Svirshchevskaya EV; Vodovozova EL; Fedorov AY
J Liposome Res; 2024 Sep; 34(3):399-410. PubMed ID: 37867342
[TBL] [Abstract][Full Text] [Related]
14. The novel melphalan prodrug J1 inhibits neuroblastoma growth in vitro and in vivo.
Wickström M; Johnsen JI; Ponthan F; Segerström L; Sveinbjörnsson B; Lindskog M; Lövborg H; Viktorsson K; Lewensohn R; Kogner P; Larsson R; Gullbo J
Mol Cancer Ther; 2007 Sep; 6(9):2409-17. PubMed ID: 17876040
[TBL] [Abstract][Full Text] [Related]
15. Theranostic Liposomes with Hypoxia-Activated Prodrug to Effectively Destruct Hypoxic Tumors Post-Photodynamic Therapy.
Feng L; Cheng L; Dong Z; Tao D; Barnhart TE; Cai W; Chen M; Liu Z
ACS Nano; 2017 Jan; 11(1):927-937. PubMed ID: 28027442
[TBL] [Abstract][Full Text] [Related]
16. Hemocompatibility of liposomes loaded with lipophilic prodrugs of methotrexate and melphalan in the lipid bilayer.
Kuznetsova NR; Sevrin C; Lespineux D; Bovin NV; Vodovozova EL; Mészáros T; Szebeni J; Grandfils C
J Control Release; 2012 Jun; 160(2):394-400. PubMed ID: 22210161
[TBL] [Abstract][Full Text] [Related]
17. Differential binding of plasma proteins by liposomes loaded with lipophilic prodrugs of methotrexate and melphalan in the bilayer.
Kuznetsova NR; Vodovozova EL
Biochemistry (Mosc); 2014 Aug; 79(8):797-804. PubMed ID: 25365489
[TBL] [Abstract][Full Text] [Related]
18. Preclinical activity of nanoliposomal irinotecan is governed by tumor deposition and intratumor prodrug conversion.
Kalra AV; Kim J; Klinz SG; Paz N; Cain J; Drummond DC; Nielsen UB; Fitzgerald JB
Cancer Res; 2014 Dec; 74(23):7003-13. PubMed ID: 25273092
[TBL] [Abstract][Full Text] [Related]
19. Liposomal formulation of alpha-tocopheryl maleamide: in vitro and in vivo toxicological profile and anticancer effect against spontaneous breast carcinomas in mice.
Turánek J; Wang XF; Knötigová P; Koudelka S; Dong LF; Vrublová E; Mahdavian E; Procházka L; Sangsura S; Vacek A; Salvatore BA; Neuzil J
Toxicol Appl Pharmacol; 2009 Jun; 237(3):249-57. PubMed ID: 19480910
[TBL] [Abstract][Full Text] [Related]
20. Bivalent bendamustine and melphalan derivatives as anticancer agents.
Scutaru AM; Wenzel M; Gust R
Eur J Med Chem; 2011 May; 46(5):1604-15. PubMed ID: 21371790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
